
Opinion|Videos|April 22, 2024
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease
Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Advertisement
Timecodes:
1:28 Defining ON time in PD
4:50 Dyskinesia experience
8:00 Tremor and dyskinesia
13:30 Dyskinesia and QoL
16:00 Dyskinesia and OFF
19:30 Tailoring treatment
22:00 Amantadine DR/ER
29:00 Amantadine candidates
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
4
Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib
5











